TIMP-2 as a noninvasive urinary marker for predicting neurogenic bladder in patients under follow-up for spina bifida.

Shubhalaxmi Nayak Monika BawaRavi P KanojiaArnab PalAnu JainRam Samujh

Published in: Neurourology and urodynamics (2020)

This study highlights the potential of urinary marker TIMP-2 as noninvasive and cost-effective test to initially diagnose and predict the progression of disease in NBs with reasonable sensitivity and specificity.

Keyphrases

end stage renal disease
spinal cord injury
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
risk assessment
climate change